Tag: pharma

The life sciences and pharmaceutical industry faces unique challenges in managing compliance and navigating risks across borders. In this insightful webinar, sponsored by Control Risks,  we will delve into some of the most pressing issues impacting the sector today.

Our experts will explore:

• Challenges in Cross-Border Compliance Investigations: Addressing complexities in regulatory requirements and managing multi-jurisdictional risks.
• Combatting Counterfeiting, Theft, and Parallel Import: Strategies for investigations in high-risk jurisdictions.
• Navigating Sanctions: Practical guidance for companies operating in increasingly regulated global markets.
• Regulatory Developments and Enforcement Trends: Insights into anticipated government actions under the new US administration and their implications for compliance.

This session will provide actionable insights and practical strategies for investigators, compliance professionals, and risk managers to safeguard operations in this highly regulated and dynamic sector.

 

Register

 

Panel

 

Ashu Sharma, ACi Executive Committee

Ash Sharma has over 20 years’ experience in investigations and financial crime risk mitigation. Ash presently manages one of two global investigation hubs for Anglo American Plc, a global mining, minerals and extraction company.  His team conduct corporate ethics and compliance (including regulatory and financial crime) investigations. Ash has worked in the UK and Asia in regional and group roles for a global bank. There, he headed up an internal fraud risk, background vetting and investigation function, before leading and coordinating global significant investigations for the group.  Ash is a Certified Fraud Examiner, Certified Financial Crime Specialist, and Certified Cryptocurrency Investigator.

 

 

Tristan Grimmer, Partner, Baker McKenzie

Tristan is a Partner at Baker McKenzie, advising clients on sanctions and export controls, anti-bribery and corruption and other corporate compliance risks. He provides compliance advice to clients across these risk areas, including in the context of complex cross-border transactions, as well as supporting clients in the management of related internal and external investigations. Tristan has advised clients in respect of investigations by the Serious Fraud Office, the Office of Financial Sanctions Implementation (OFSI), the National Crime Agency, HM Revenue & Customs, and the Competition and Markets Authority, as well as in related investigations by overseas agencies, including the US Department of Justice and the Office of Foreign Assets Control (OFAC). He also counsels clients in the design and implementation of their corporate compliance programmes. Tristan is the UK head of Baker McKenzie’s market leading international trade practice, which is ranked as Tier 1 by Legal 500 and Band 1 by Chambers UK. He is personally ranked as a Leading Individual for ‘Trade, WTO, Anti-dumping and Customs’ by Legal 500 and for ‘Sanctions’ by Chambers UK. He is the EMEA Chair of the firm’s Investigations, Compliance & Ethics practice.

 

Martina Rozumberkova, Principal, Control Risks

Martina Rozumberkova is a Principal within Control Risks’ Compliance, Forensics and Intelligence practice in the Americas. She has over 17 years of experience assisting companies with fraud and forensic investigations as well as reviews, assessments, development and implementation of global compliance programs, and internal controls. She advises companies conducting investigations involving the FCPA and helps address regulatory actions with focused expertise assisting the life science industry. She has also led teams conducting regulatory mandated monitorships.

 

 

Whitney Potts, Head Global Security Investigations, Novartis International AG (Switzerland)

Whitney Potts is an accomplished and agile global risk, compliance and legal professional currently serving as the Deputy Head of Global Security and Head of Global Security Investigations at Novartis International. As the Global Security Head of Investigations for Novartis, Whitney oversees a team of expert investigators around the world who investigate allegations of high-risk misconduct and recommend remediation actions. Previously, she held senior roles including as Head of Ethics, Risk & Compliance as well as Head of Legal, Oncology for the region covering Asia, Middle East, Africa and China at Novartis Pharmaceuticals, where she was responsible for the legal and compliance aspects of region-wide strategies, programs and initiatives and developing and delivering the Ethics, Risk & Compliance program, supervising regional enterprise risk assessments (anti-bribery, third party), compliance audits, monitoring, and remediation of issues including those from internal investigations. Whitney is a Certified Fraud Examiner, licensed attorney and a graduate of Columbia Law School in New York.

 

 

 

 

Sponsored by